Vapes become more toxic as they run out of fluid
A new study is raising serious concerns about what vape users are actually inhaling toward the end of a device’s life. Researchers at the University of California, Riverside found that toxic aldehyde compounds become increasingly concentrated in the remaining fluid of high-puff-count vapes as they near depletion, meaning the last draws from a used device may expose users to significantly higher levels of harmful chemicals than the first.
The research, published in ACS Omega, analyzed 77 devices from 20 brands. Scientists compared the chemical composition of residual fluid in used vapes against fresh, unused versions of the same products. In total, nearly 200 chemical components were identified across the devices, including 9 aldehydes that were not disclosed by the manufacturers.
The specific toxins building up inside used vapes
Two compounds in particular stood out. Methylglyoxal and glyoxal were found at notably higher concentrations in all of the used devices compared to their unused counterparts. Researchers believe these compounds form through thermal breakdown of the carrier solution during the heating cycle that occurs with each puff.
The health implications of this buildup are significant. Previous research has established that methylglyoxal is more damaging to lung tissue than diacetyl, the compound responsible for a condition known as popcorn lung, a serious and irreversible lung disease linked to chemical exposure. The UC Riverside team demonstrated this toxicity directly in a lab setting. Within just nine puffs of methylglyoxal, bronchial cells showed clear signs of stress, including a physical change in cell shape that researchers use as a key marker of cellular damage.
The invisible threat that disappears into the lungs
One of the more alarming findings from the research involves what was not found in used vapes rather than what was. In initial analysis of unused devices, several brands contained the aldehyde acrolein, a compound known to be highly toxic even at very low concentrations. However, in the used devices, acrolein had largely disappeared or dropped to undetectable levels.
Researchers interpret this absence not as reassurance but as evidence that acrolein is being inhaled. Because the compound was present before use and is known to form during the vaping process, its disappearance from residual fluid strongly suggests it is evaporating into the vapor that users breathe in. This means one of the most acutely toxic aldehydes linked to vaping may be entering the lungs in ways that are not captured by analyzing the fluid alone.
What researchers say needs to happen next
Scientists not involved in the study noted that the findings open an important window into the chemistry of vaping that remains poorly understood. The aldehydes detected in the residual fluid follow specific chemical pathways, and their presence provides clues about what more volatile compounds may already have been inhaled before the device was discarded.
Researchers also flagged the need for studies that go beyond fluid analysis to examine the actual vapor composition that reaches the lungs. What remains in the chamber after vaping is not the same as what a person inhales, and understanding that difference is critical to assessing the true health risk. The concern is especially acute for high-puff-count devices, which concentrate these toxicants over a longer period of use and therefore extend the window of exposure.
The findings suggest the risk is not limited to any single brand or flavor. The pattern of toxic aldehyde accumulation appeared consistent across all the products tested, raising questions about the broader safety of disposable and high-capacity vape devices.